Kintara Therapeutics Inc (NASDAQ:KTRA) has a beta value of 0.41 and has seen 51.14 million shares traded in the last trading session. The company, currently valued at $8.23M, closed the last trade at $0.15 per share which meant it lost -$0.01 on the day or -5.82% during that session. The KTRA stock price is -3886.67% off its 52-week high price of $5.98 and 46.67% above the 52-week low of $0.08. The 3-month trading volume is 14.04 million shares.
Kintara Therapeutics Inc (NASDAQ:KTRA) trade information
Sporting -5.82% in the red in last session, the stock has traded in the green over the last five days, when the KTRA stock price touched $0.15 or saw a rise of 23.08%. Year-to-date, Kintara Therapeutics Inc shares have moved -12.26%, while the 5-day performance has seen it change 22.57%. Over the past 30 days, the shares of Kintara Therapeutics Inc (NASDAQ:KTRA) have changed 66.26%.
Kintara Therapeutics Inc (KTRA) estimates and forecasts
The company’s shares have lost -96.19% over the past 6 months, compared to 12.90% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 49.09% over the past 5 years.
KTRA Dividends
Kintara Therapeutics Inc is expected to release its next earnings report in May this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
